This is a $127,208.86 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of 60-count bottles of the generic drug valganciclovir 450 mg tablets. The order has an ultimate completion date of January 9, 2025. Amerisourcebergen holds a large $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This is a $2,703.97 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Valganciclovir 450 mg tablets in 60-count packages, with a period of performance through June 9, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Valganciclovir 450 mg tablets. The fixed-price contract has a ceiling value of $1,559.32 and a completion date of February 9, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,662.65 firm fixed-price contract is for the delivery of 60 tablets of the medication valganciclovir 450 mg. The contract has a performance period through January 5, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and there is no...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60-count bottles of the drug Valganciclovir 450 mg tablets, with a ceiling value of $3,193.93 and a period of performance through April 14, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VALGANCICLOVIR 450 MG TABLET UD 20S. The contract has a ceiling value of $1,419.23 and a period of performance through July 7, 2025. This award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical. The IDC allows AmerisourceBergen to supply a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, with a ceiling value of $1,546.87, is for the supply of Valganciclovir 450 mg tablets over a period ending on June 21, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This is a $29,588.22 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4567474784 - VALGANCICLOVIR 450 MG TABLET 60S. The order has a period of performance through March 6, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. This award is part of a larger...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 450 mg valganciclovir tablets, a medication used to treat cytomegalovirus infections. The contract has a ceiling value of $2,477.97 and a performance period ending on June 17, 2025. This contract is not set aside and was competitively awarded. AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,951.32 firm fixed-price contract is for the delivery of valganciclovir hydrochloride 50 mg/mL oral solution. The ultimate completion date is November 14, 2024. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract...